loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 91426 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 AMNEAL PHARMS (3)

filter

01 TABLET;ORAL (3)

filter

01 RX (3)

filter

01 SPIRONOLACTONE (3)

filter

01 No (3)

URL Supplier Web Content
TABLET; ORAL
100MG
2010-07-02
91426
SPIRONOLACTONE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
25MG
2010-07-02
91426
SPIRONOLACTONE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
50MG
2010-07-02
91426
SPIRONOLACTONE
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 91426

Looking for FDA Orange Book APPLICATION 91426 3

19

Amneal Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is SPIRONOLACTONE, with a corresponding application number 91426.

Regulatory Information RX

With a dosage strength 100MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2010-07-02

Therapeutic Equivalence (TE) Code AB

18

Amneal Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is SPIRONOLACTONE, with a corresponding application number 91426.

Regulatory Information RX

With a dosage strength 25MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2010-07-02

Therapeutic Equivalence (TE) Code AB

17

Amneal Pharmaceuticals, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is SPIRONOLACTONE, with a corresponding application number 91426.

Regulatory Information RX

With a dosage strength 50MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2010-07-02

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY